M&A Deal Summary

Sterling Pharma Solutions Acquires ADC Bio

On April 7, 2021, Sterling Pharma Solutions acquired life science company ADC Bio from Maven Capital Partners

Acquisition Highlights
  • This is Sterling Pharma Solutions’ 2nd transaction in the Life Science sector.
  • This is Sterling Pharma Solutions’ 1st transaction in the United Kingdom.

M&A Deal Summary

Date 2021-04-07
Target ADC Bio
Sector Life Science
Buyer(s) Sterling Pharma Solutions
Sellers(s) Maven Capital Partners
Deal Type Add-on Acquisition

Target

ADC Bio

Deeside, United Kingdom
ADC Bio specializes in developing new process technologies for antibody-drug conjugates (ADCs) which help speed up, simplify and lower the production costs of the latest generation of anti-cancer blockbuster ADC drugs. ADC Bio is based in Deeside, United Kingdom.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sterling Pharma Solutions

Northumberland, United Kingdom

Category Company
Sector Life Science
DESCRIPTION

Sterling Pharma Solutions is a provider of API development and manufacturing. Sterling delivers a full-service offering of API development and GMP manufacturing to support its customers throughout the entire product lifecycle. Sterling Pharma Solutions is based in Northumberland, United Kingdom.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
Country: United Kingdom M&A 1 of 1
Year: 2021 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-10-01 Alcami - API Facility

Germantown, Wisconsin, United States

Alcami Corp.'s API Facility provides additional capacity for customer API development and manufacturing projects, specifically those with complex and hazardous requirements.

Buy -

Seller(S) 1

SELLER

Maven Capital Partners

Glasgow, United Kingdom

Investor Investor Investor Investor Investor


Category Asset Manager
Founded 2009
PE ASSETS 760M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Maven Capital Partners UK LLP (MCP) invests in lower mid-market companies throughout the UK. The Firm also provides mezzanine financing. MCP focuses on profitable companies with proven track records, balanced management teams, and diverse products and services. Maven looks to invest £2 - £20 million in businesses valued from £10 - £40 million. Sectors of interest include specialist manufacturing, health/pharmaceuticals, energy services, leisure, financial services, software and computer services, communication/IT, chemicals, food/beverage, media, consumer products, and support services. Types of transactions include MBOs, MBIs, BIMBOs, take privates, recapitalizations, and growth capital financings. Maven Capital Partners UK LLP was formed in 2009, following a management buyout of Aberdeen Asset Management's Private Equity division. Maven is based in Glasgow with additional offices in Aberdeen, Birmingham, Edinburgh, London and Manchester.


DEAL STATS #
Overall 43 of 86
Sector: Life Science M&A 3 of 7
Type: Add-on Acquisition M&A Deals 19 of 40
Country: United Kingdom M&A 42 of 84
Year: 2021 M&A 1 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-06 Atterley.com

Edinburgh, United Kingdom

Atterley.com is an online fashion marketplace that provides a sales channel solution for boutiques and independent brands to sell to a global customer base. Atterley.com is having more than 75 global fashion brands, including Selected Femme, Whistles, Ganni, Ash and Saint James. Atterley.com was founded in 2011 and is based in Edinburgh, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-14 Cardinality

Surrey , United Kingdom

Cardinality is a supplier of cloud-native data management (DataOps), service assurance and customer experience analytics for communications service providers (CSPs) globally. Cardinality was founded in 2015 and is based in Surrey, United Kingdom.

Buy -